Montreal (QC), Toronto (ON), Vancouver (BC) — adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to developing innovative therapies for rare bone diseases…. Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company), a leading global medical technology company, announced a $110 million investment to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug… Read More
Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer… Read More
Amsterdam, NL – argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that the U.S. Food and Drug Administration (FDA) has… Read More
CHICAGO – Aon a leading global professional services firm, released updated findings from its multi-year study of U.S. commercial health claims data, building on its GLP-1 research first released in April 2025. Drawing on medical… Read More
